Patrick G. Kehoe

Patrick G. Kehoe publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Patrick G. Kehoe sits on this spectrum.

Patrick G. Kehoe D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Patrick G. Kehoe sits on this spectrum.

Best Publications

• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  Denise Harold;Richard Abraham;Paul Hollingworth;Rebecca Sims

  3441
  Citations

• Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

  Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  2310
  Citations

• Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

  Lesley Jones;Peter A. Holmans;Marian L. Hamshere;Denise Harold

  842
  Citations

• Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations

  Lucy Webster;Derek Groskreutz;Anna Grinbergs-Saull Grinbergs-Saull;Rob Howard

  598
  Citations

• Abeta-degrading enzymes in Alzheimer's disease.

  James Scott Miners;Shabnam Baig;Jennifer Palmer;Laura E Palmer

  540
  Citations

• Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

  C Cruchaga;CM Karch;SC Jin;BA Benitez

  530
  Citations

• Drug repositioning for Alzheimer's disease

  Anne Corbett;James Pickett;Alistair Burns;Jonathan Corcoran

  351
  Citations

• Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease

  James Scott Miners;Neil Barua;Patrick Gavin Kehoe;Steven Gill

  319
  Citations

• Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment

  Olivia A. Skrobot;Johannes Attems;Margaret Esiri;Tibor Hortobágyi;Tibor Hortobágyi

  294
  Citations

• Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier.

  Silke Krol;Richard Macrez;Fabian Docagne;Gilles Defer

  231
  Citations

• Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease?

  Patrick Gavin Kehoe;Gordon K Wilcock

  225
  Citations

• Cognitive impact of COVID-19: looking beyond the short term.

  Scott Miners;Patrick G. Kehoe;Seth Love

  203
  Citations

• Convergent genetic and expression data implicate immunity in Alzheimer's disease

  Lesley Jones;Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Li-San Wang;Seung-Hoan Choi

  195
  Citations

• Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.

  James Scott Miners;Zoë Van Helmond;Katy Chalmers;Gordon Wilcock

  193
  Citations

• Angiotensins in Alzheimer's disease – friend or foe?

  Patrick G. Kehoe;Scott Miners;Seth Love

  190
  Citations

• Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes

  Scott Miners;Emma Ashby;Shabnam Baig;Rachel Harrison

  189
  Citations

• Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.

  J S Miners;EL Ashby;Z van Helmond;Katy A Chalmers

  184
  Citations

• ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease

  Charles E. Evans;James S. Miners;Giulia Piva;Christine L. Willis

  141
  Citations

• Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis

  Ruth Peters;Ruth Peters;Sevil Yasar;Craig S. Anderson;Craig S. Anderson;Craig S. Anderson;Shea Andrews

  140
  Citations

• VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro

  Nick Beazley-Long;Jing Hua;Thomas Jehle;Richard P. Hulse

  131
  Citations